Role of CaCO3 alone and CaCO3 plus vitamin D3 in terms of calcium phosphorus product in chronic kidney diseases

J Nepal Health Res Counc. 2011 Apr;9(1):67-70.

Abstract

Background: CaCO3 alone and CaCO3 plus vitamin D3 metabolites are commonly prescribed in CKD patients. The objective of this study is to analyze the changes in Ca x P product, calcium level and phosphorus level in CKD patients receiving calcium carbonate alone and calcium carbonate with vitamin D3 in combination.

Methods: A prospective, cross sectional study among CKD patients under maintenance hemodialysis two times a week were studied over a period of one year. The patients were divided into two groups receiving oral CaCO3 alone and CaCO3 plus vitamin D3 once a day. The patients were followed for 1 month and result of Ca x P product was analyzed accordingly.

Results: Mean decrease of Ca x P product in CaCO3 group is (50.42+/-8.85 to 47 +/-6.63) in one month, p value =0.001(0.6-5) and CI- 95%. There is also significant reduction of phosphorus level in CaCO3 group than CaCO3 plus vitamin D3 group. Mean decrease in phosphorus in CaCO3 group is (5.51+/-0.76 to 5.17+/- 0.05) in one month. P value =0.01(0.14-0.53) and CI 95%.

Conclusions: There is a significant decrease in Ca x P product and phosphorus level was observed in CKD patients taking CaCO3 alone.

MeSH terms

  • Adult
  • Antacids / therapeutic use*
  • Calcium / metabolism*
  • Calcium Carbonate / therapeutic use*
  • Cholecalciferol / therapeutic use*
  • Cross-Sectional Studies
  • Drug Therapy, Combination / methods
  • Female
  • Humans
  • Kidney Failure, Chronic / drug therapy*
  • Male
  • Middle Aged
  • Nepal
  • Phosphorus / metabolism*
  • Prospective Studies
  • Renal Dialysis
  • Vitamins / therapeutic use*

Substances

  • Antacids
  • Vitamins
  • Cholecalciferol
  • Phosphorus
  • Calcium Carbonate
  • Calcium